Sincrolab

sincrolab.es ↗ ·Madrid ·Seed

Sincrolab is a Madrid-based digital therapeutics company that builds AI-personalised cognitive training delivered as prescribable video games, with its flagship product Sea of Heroes treating ADHD in children aged roughly 7-15 plus solutions for adults with cognitive impairment. Founded by clinical neuropsychologists, it works with 800+ therapists and over 100 specialised centres and backs its products with published clinical evidence. It is a seed-stage healthtech that raised a €1.7M round in early 2025 led by Clave Capital's Clave Innohealth fund, with a follow-on from Eoniq.fund in June 2026 at a reported €8.5M pre-money valuation.

Founded

2013

Founders

Total funds raised

€2.8M

SectorsHealthtech, Digital Therapeutics, AI, Mental Health, Medtech Start-up MapHealthtech & Bio › Consumer & telehealth services

Suggest a correction

Founders

Daniel Garrido

Co-founder (former CTO)

Ignacio de Ramón Burgos

CEO & Co-founder

María Laorden Baeza

Co-founder

Global models 5

Pear Therapeutics

United States · peartherapeutics.com ↗

Built FDA-cleared prescription digital therapeutics that clinicians prescribe and payers reimburse, the same prescribable-software model Sincrolab uses.

$410MComparable

MindMaze

Switzerland · mindmaze.com ↗

Sells clinically validated, game-based neurorehabilitation and cognitive therapy to clinics and therapists for patients with neurological impairment.

$340MComparable

Akili Interactive

United States · www.akiliinteractive.com ↗

Its EndeavorRx is an FDA-authorised, prescribable video game that treats ADHD in children, the closest direct match to Sea of Heroes.

$300MComparable

Click Therapeutics

United States · www.clicktherapeutics.com ↗

Develops clinically validated prescription digital therapeutics for neurological and psychiatric conditions, delivered as software through clinicians.

$100MComparable